sun pharma stock price analysis 2013

sun pharma stock price daily chart technical analysis

sun pharma share on last trading session closed at 592 with gains.on daily chart trend and momentum bullish.on downside 550-570 are short term support levels.and on upside trading at new all time high.

on all given chart averages are not right as slit/bonus is not adjusted.but technically strong bullish and short term traders keep buy on dips view.

from short term view,buy near 570 with stoploss below 550 and expect target 620 and then 670 on upside.


sun pharma share price weekly chart technical analysis

sun pharma share on weekly charts shows bullish trend and continues buying demand.on weekly chart 480 is major bottom and above this keep buy on dips view for upside targets.

from medium term view,above 410 keep bullish view for this stock and with weekly closing basis stoploss below 530 investors and traders can expect upside target of 655 and then 715 in medium terms.


sun pharma share price monthly chart technical analysis

sun pharma share on monthly chart showing strong bullish trend and closed with gains in sep 2013.on chart looks some what overbought but as defensive sector and supporting fundamentals we still expect higher levels here.this is good fundamental stock with international recognitions and from defensive sectors.must keep in your portfolio and expect higher targets.

my personal view is 440-500 is accumulation zone for investors wit weekly closing basis stoploss below 400 and my personal target for this stock will be 680 in next 12 months time frame.

The Author

Pramod Baviskar

Professional Market Trader And Owner Of Dalal Street Winners Advisory And Coaching Services. Working Since 2007 And Online Presence Since 2010. We Provide Highly Accurate And Professional 1 Entry And 1 Exit Future, Option, Commodity, Currency And Intraday Stock Tips On Whatsapp With Live Support And Follow Up.
COPYRIGHT © 2009-2018. Pramod Baviskar. Dalal street winners advisory and coaching services. FAQ | Disclaimer | Privacy Policy

This website is best viewed using Microsoft Internet Explorer 9 or higher, and/or latest version of Google Chrome and Mozila Firefox browsers.